193 related articles for article (PubMed ID: 33046429)
1. Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids.
Strand T; Kives S; Leyland N; Ashkenas J; Janiszewski P; Thiel J
J Obstet Gynaecol Can; 2020 Dec; 42(12):1475-1482.e2. PubMed ID: 33046429
[TBL] [Abstract][Full Text] [Related]
2. Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial.
de Milliano I; Huirne JAF; Thurkow AL; Radder C; Bongers MY; van Vliet H; van de Lande J; van de Ven PM; Hehenkamp WJK
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):89-98. PubMed ID: 31468503
[TBL] [Abstract][Full Text] [Related]
3. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
4. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
5. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
Obstet Gynecol; 2021 Jun; 137(6):e100-e115. PubMed ID: 34011888
[TBL] [Abstract][Full Text] [Related]
6. Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States.
Bonine NG; Banks E; Harrington A; Vlahiotis A; Moore-Schiltz L; Gillard P
BMC Womens Health; 2020 Aug; 20(1):174. PubMed ID: 32791970
[TBL] [Abstract][Full Text] [Related]
7. Contemporary management of uterine fibroids: focus on emerging medical treatments.
Singh SS; Belland L
Curr Med Res Opin; 2015 Jan; 31(1):1-12. PubMed ID: 25365466
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
9. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
[TBL] [Abstract][Full Text] [Related]
10. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
11. Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results.
Fernandez H; Schmidt T; Powell M; Costa AP; Arriagada P; Thaler C
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():91-96. PubMed ID: 27898340
[TBL] [Abstract][Full Text] [Related]
12. Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant.
Pécout M; Cosson M; Collinet P; Rubod C; Giraudet G
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):781-783. PubMed ID: 30898625
[TBL] [Abstract][Full Text] [Related]
13. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
14. Update on medical treatment of uterine fibroids.
Faustino F; Martinho M; Reis J; Águas F
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():61-68. PubMed ID: 28732252
[TBL] [Abstract][Full Text] [Related]
15. [LAPAROSCOPIC MYOMECTOMY AFTER ULIPRISTAL ACFTATF TRFATMFMT.].
Blagovest B; Magunska N
Akush Ginekol (Sofiia); 2016; 55(5):29-31. PubMed ID: 29790712
[TBL] [Abstract][Full Text] [Related]
16. Medical or surgical management of fibroids? An internet survey of gynecologists' views.
Pazzaglia E; Praet J; Vandromme J; Rozenberg S
Maturitas; 2017 Jan; 95():6-10. PubMed ID: 27889055
[TBL] [Abstract][Full Text] [Related]
17. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
18. A multi-centre, randomized, non-inferiority trial to compare ulipristal with standard surgical treatment in women with symptomatic uterine fibroids: Protocol of the MYOMEX-2 trial.
Middelkoop MA; Huirne JAF; van der Weide MCJ; Bosmans JE; Hehenkamp WJK;
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():63-69. PubMed ID: 33171419
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database.
Borah BJ; Yao X; Laughlin-Tommaso SK; Heien HC; Stewart EA
Obstet Gynecol; 2017 Nov; 130(5):1047-1056. PubMed ID: 29016510
[TBL] [Abstract][Full Text] [Related]
20. Uterine fibroid management: from the present to the future.
Donnez J; Dolmans MM
Hum Reprod Update; 2016 Nov; 22(6):665-686. PubMed ID: 27466209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
